IP Library Patent Application 15904882
Patent Application
App. No. 15/904,882

COMPOUNDS AND METHODS FOR TREATING INFLAMMATORY DISEASES

Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US None
App. No.
15/904,882
Abstract

Described herein are compounds and pharmaceutical compositions useful for treating inflammatory diseases.

Claims (25)

1 . A compound of the formula

or a pharmaceutically acceptable salt thereof, wherein:

R 1 is in each instance independently selected from the group consisting of hydrogen, acyl, and alkyl, cycloalkyl, heteroalkyl, heterocyclyl, heterocyclylalkyl, heterocyclylheteroalkyl aryl, arylalkyl, and arylheteroalkyl, each of which is optionally substituted; or R 1 are taken together with the attached nitrogen to form an optionally substituted heterocycle or optionally substituted heteroaryl; or R 1 are taken together with the attached nitrogen to form azido;

R 5 is in each instance independently hydrogen, alkyl, alkenyl, or alkynyl;

R a is an amino saccharide, wherein at least one amino group is not dimethylamino; and

W is H or F;

X is alkylene, heteroalkylene, a divalent carbocycle, or a divalent heterocycle, each of which is optionally substituted;

Y taken together with the attached carbon forms a carbonyl, imine, oxime, or hydrazone, or Y represents H, OR 5 ; and

Z taken together with the attached carbon forms a carbonyl, imine, oxime, or hydrazone, or Z represents Z a , OR b , where Z a is H; and R b is hydrogen, acyl, or a saccharide, or alkyl or arylalkyl, each of which is optionally substituted.

2 .- 20 . (canceled)

21 . The compound of claim 1 wherein R a is a desosamine derivative.

22 . The compound of claim 21 wherein R a is a radical of the formula

where R N1 is hydrogen or optionally substituted C 2 -C 24 alkyl; and R N2 is hydrogen, optionally substituted C 1 -C 24 alkyl, or optionally substituted C 3 -C 24 cycloalkyl.

23 . The compound of claim 22 wherein R N2 is optionally substituted C 1 -C 24 alkyl.

24 . The compound of claim 22 wherein R N2 is optionally substituted C 1 -C 6 alkyl.

25 . The compound of claim 22 wherein R N2 is optionally substituted C 3 -C 24 cycloalkyl.

26 . The compound of claim 22 wherein R N2 is optionally substituted C 3 -C 8 cycloalkyl.

27 . The compound of claim 21 wherein R a is a radical of the formula

where R N1 is hydrogen or alkyl.

28 . The compound of claim 1 wherein R 5 is alkyl.

29 . The compound of claim 1 wherein X is alkylene.

30 . The compound of claim 1 wherein Y taken together with the attached carbon forms a carbonyl.

31 . The compound of claim 1 wherein Z represents Z a , OR b , where Z a is H; and R b is hydrogen, acyl, or a saccharide, or alkyl or arylalkyl, each of which is optionally substituted.

32 . The compound of claim 31 wherein Z a is H; and R b is a saccharide.

33 . The compound of claim 1 wherein Z taken together with the attached carbon forms a carbonyl.

Assignments (3)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 14, 2019
From: CEMPRA PHARMACEUTICALS, INC.
To: TETARD, INC.
Reel/Frame 050056/0731 →
RELEASE OF SECURITY INTEREST Recorded Jun 4, 2019
From: CORTLAND CAPITAL MARKET SERVICES LLC
To: CEMPRA PHARMACEUTICALS, INC.
Reel/Frame 049363/0706 →
SECURITY INTEREST Recorded Jul 25, 2018
From: MELINTA THERAPEUTICS, INC.; REMPEX PHARMACEUTICALS, INC.; CEMPRA PHARMACEUTICALS, INC.; MELINTA SUBSIDIARY CORP.
To: CORTLAND CAPITAL MARKET SERVICES LLC, AS AGENT
Reel/Frame 046454/0392 →